These effects culminated in the robust activation of NLRP3 inflammasome signaling pathway in DCs, leading to substantial secretion of IL-1β, which was essential for the priming of IFNγ-producing, tumor antigen-specific CD8+ T cells. This evidence concerns the gene NLRP3 and neoplasm.